Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PSC-100
- Development stage
- Unknown
- Lead developer
- Bristol Myers Squibb
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
PSC-100 is a proprietary placental-derived stem cell (HPDSC) population originally developed by Celgene Cellular Therapeutics and later licensed to and acquired by Human Longevity, Inc. (HLI). The therapy consists of stem cells extracted from the placenta, which are characterized by their regenerative potential and immunomodulatory properties. PSC-100 has been investigated for the treatment of sarcopenia (age-related muscle loss) and in combination with umbilical cord blood (UCB) for hematologic malignancies and non-malignant disorders to support hematopoietic recovery and immune function restoration. Celularity, which acquired Celgene's cell therapy assets, has also been involved in the distribution and manufacturing rights for the product in Asian markets.
- Other names
- human placental-derived stem cellsHPDSCplacental stem cell population
Beyond the preview
Go deeper on PSC-100.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PSC-100.